Opendata, web and dolomites


NightWatch - Clinically-proven detection and alert system for critical nocturnal epileptic seizures.

Total Cost €


EC-Contrib. €






 NIGHTWATCH project word cloud

Explore the words cloud of the NIGHTWATCH project. It provides you a very rough idea of what is the project "NIGHTWATCH" about.

tested    mind    uncontrolled    combination    severe    33    worldwide    prevented    intramural    90    accumulated    spin    types    40    livassured    depression    patients    deaths    automatically    algorithm    19m    death    epilepsy    relief    sudep    caregivers    medication    30    urgent    2013    commercial    continuous    seizures    monitor    suffer    46    detects    seizure    movement    improves    critical    alarm    full    patient    caused    heart    attending    registered    social    lack    medical    adapting    preferred    time    ai       created    wirelessly    clinically    unexpected    remote    pushing    conceived    care    giving    leads    societal    quality    billion    life    tele    nocturnal    profit    monitoring    minimize    roi    followed    peace    despite    self    reducing    detect    sleep    patterns    sudden    america    specialised    market    anxiety    die    reduces    device    least    heavy    gt    nightwatch    rate    wearables    company    flagship    dutch    prevents    50m    off    trend    institutes    28    independency    professionals    2019    more    uses    false    seek    home    bracelet    seconds    north    notifies    people    wards    few   

Project "NIGHTWATCH" data sheet

The following table provides information about the project.


Organization address
city: VUGHT
postcode: 5261AD
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIVASSURED BV NL (VUGHT) coordinator 50˙000.00


 Project objective

More than 50M people worldwide suffer from epilepsy, characterized by uncontrolled seizures, and about 30% find no relief from those despite taking medication. Nocturnal seizures can be critical; each year at least 33.000 people in EU die of Sudden Unexpected Death in Epilepsy (SUDEP), 40% of which could be prevented by attending the seizures on time. This is a continuous challenge for patients and caregivers, with important social and societal consequences (anxiety, depression, lack of sleep), and high intramural care costs (over €20 billion per year in EU). The NightWatch is a registered medical device that detects and notifies wirelessly remote caregivers in case of heavy nocturnal seizures in just few seconds. The bracelet uses a combination of heart rate and movement measurement, a unique AI algorithm conceived by three Dutch institutes specialised in epilepsy, automatically adapting to different patient patterns to minimize false alarm rate. It has been clinically tested and can detect > 90% of all types of urgent nocturnal seizures making it the most reliable system available. The NightWatch targets caregivers, patients and professionals who seek an effective alarm system for severe nocturnal seizures. It improves their quality of life giving them peace of mind, higher level of independency, reduces cost of care by reducing the need for intramural attention, and prevents deaths caused by SUDEP. With a trend to-wards home care and self-monitoring pushing market growth (expected to reach €4.0 billion in 2019), wearables becoming the preferred type of seizure monitoring. EU leads the seizure monitor devices market (46%), followed by North America (28%). NightWatch is the flagship product of LivAssured, a Dutch company created in 2013 as a spin-off to take over the commercial exploitation of the research results of the Tele-Epilepsy Consortium on nocturnal seizures. With its full commercial exploitation, we expect an accumulated profit of €19M and a ROI of 4

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGHTWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGHTWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

ChromicGlass (2019)


Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More